The Nurse View: Overcoming Challenges Associated With Cancer Immunotherapy.

Slides:



Advertisements
Similar presentations
Advancing Care Forward in Squamous Cell Carcinoma of the Head and Neck
Advertisements

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Individualizing Treatment Options in Advanced ER-Positive Breast Cancer.
Immunotherapies: Key Considerations in the Identification and Management of irAEs.
The Nurse View: Hormone Receptor-Positive Advanced Breast Cancer
The Immune System. The Immune System Adaptive Immune Response.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
T-Cell Exhaustion: Can We Overcome It in Cancer?
Advances in Managing Inhibitors in Patients With Hemophilia A
State of the Art in HCC: Immune Checkpoint Modulation
Case Studies.
Challenges in the Diagnosis of MS: Physician and Nurse Perspectives
Progression After Cancer Immunotherapy in Advanced NSCLC
Introduction. Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Endocrine System.
Introduction to Checkpoint Inhibitors
Spotlight on Immuno-Oncology in Melanoma
The ABCs of Nitric Oxide in the Skin
Hot Topics in Hemophilia Nursing
Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.
Activity Goals. Activity Goals Discussion Topics.
Expanding Treatment Horizons in Head and Neck Cancer: TRK Inhibitors
Immunotherapy in Pancreatic Cancer: Thinking Outside the Box
Optimizing Management of Advanced Bladder Cancer
Checkpoint Inhibition
Improving Management of Type 2 Diabetes in Hispanic/Latino Patients
Team-Based Perspectives on Successful Approaches in Treating Obesity
Checkpoint Inhibition
Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Genitourinary Tract.
The Emerging Role of Immunotherapy in Hodgkin Lymphoma
Optimizing Outcomes and Managing Adverse Events in CLL
A Primer on Medication Delivery Systems in COPD Management
Immunotherapy for cSCC
Evolving Concepts in the Management of Head and Neck Cancers
Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.
A Primer on Medication Delivery Systems in COPD Management
Immune Checkpoint Inhibitors in Lung Cancer
Locally Advanced Lung Cancer
Patient-Centered Management in BRAF-Positive Metastatic Melanoma
EGPA.
Moving the Goal Post: Multidisciplinary Management of Advanced NSCLC
Biomarker Testing: Harnessing All Sides of the Tumor Microenvironment
Management of Advanced Pancreatic Adenocarcinoma
Patient-Centered Management in Advanced Non-Small Cell Lung Cancer
Optimizing Joint Health in Hemophilia
Possible Causes of imAEs
Challenges and Opportunities
Preparing for Checkpoint Inhibitors in Breast Cancer
Novel Concepts in the Management of RCC
Debates and Dilemmas, Part 1
From Adjuvant to Metastatic in Melanoma
Strengthening Lung Cancer Team Connections to Improve Outcomes With Immunotherapy.
The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Activity Goals. Clinical Considerations in the Use of Immune Checkpoint Inhibitors in Advanced NSCLC.
Navigating New Treatment Landscapes in HR+ HER2-Negative Advanced Breast Cancer.
Optimizing Outcomes in mRCC: Finding the Balance of Immune Inhibition
This program will include a discussion of off-label treatment or use of investigational agents not approved by the FDA for use in the US, and data that.
Clinical Considerations in the Use of Checkpoint Inhibitors Breast Cancer.
The Nurse View: Spotlight on EGFR-Mutated NSCLC
A Pharmacist's Guide to Safety and Use of Immune Checkpoint Inhibitors
Case Studies in Peanut Allergy Immunotherapy
Moving Care Forward in Advanced Gastric Cancer
Mitigating Side Effects and Optimizing Compliance With Oral Therapies in CLL.
Immune Checkpoint Inhibitors in Lung Cancer
Exploring the Use of Adeno-Associated Virus for Gene Therapy
The Nurse View.
The Nurse View: Practice Pearls in the Use of Immune Checkpoint Inhibitors in Advanced NSCLC.
Overview of irAEs. Management of Immune-Related Adverse Events for Patients Receiving Checkpoint Inhibitor Therapy.
Glucose levels must be monitored in patients receiving steroids for immunotherapy-related toxicity Title: Subtitle Risk Assessment of Hyperglycaemia Induced.
Best Practices in Building HIV Care Networks
Presentation transcript:

The Nurse View: Overcoming Challenges Associated With Cancer Immunotherapy

Introduction Checkpoint Inhibitors

Introduction (cont)

Immune System Regulation

Setting Patient Expectations

Partnering With Patients

Explaining Tumor Response

Explaining the Process

Patient Resources

Expectations for Patient Communication

Immune-Related Adverse Effects

Gastrointestinal

Gastrointestinal (cont)

Gastrointestinal (cont)

Endocrine

Multidisciplinary Team

Steroid Management

Laboratory Work

Holding Treatment

Skin

Skin (cont)

Pneumonitis

Nervous System

Other irAEs

Common Management Strategies

Discontinuing Treatment

Concluding Remarks

Abbreviations

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.